Full Professor(heuristic)
Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine
Compare more Pulmonary and Respiratory Medicine professors.
h-index79
i10-index205
Publications443
Citations30,855
Grants
No NSF/NIH grants on record.
Recent Public Signals
- New paper: Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer (Investigational New Drugs)2025-12-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-25
Data may not be current
Find elsewhere
ORCID: 0000-0001-9877-8512